Pharmacoeconomical rationale for switching of patients with type 1 diabetes mellitus to the short-acting insulin analogue Aspart (Novorapid*)

O V Ushakova; I A Shapiro

doi:10.14341/probl10870-8767

For citations:

Ushakova O.V., Shapiro I.A. Pharmacoeconomical rationale for switching of patients with type 1 diabetes mellitus to the short-acting insulin analogue Aspart (Novorapid*). Problems of Endocrinology. 2006;52(4):9-12. (In Russ.) https://doi.org/10.14341/probl20065249-12

Views PDF (Rus): 148

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Problems of Endocrinology

For citations:

Cookies policy